Pinnacle Associates’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-135,344
| Closed | -$17.9M | – | 864 |
|
|
2025
Q1 | $17.9M | Sell |
135,344
-9,320
| -6% | -$1.23M | 0.26% | 90 |
|
|
2024
Q4 | $12.1M | Sell |
144,664
-31,460
| -18% | -$2.63M | 0.16% | 130 |
|
|
2024
Q3 | $12.6M | Buy |
176,124
+5,055
| +3% | +$362K | 0.21% | 128 |
|
|
2024
Q2 | $11.7M | Sell |
171,069
-2,823
| -2% | -$193K | 0.18% | 131 |
|
|
2024
Q1 | $12M | Sell |
173,892
-2,232
| -1% | -$154K | 0.19% | 134 |
|
|
2023
Q4 | $12.6M | Sell |
176,124
-1,094
| -0.6% | -$78.4K | 0.21% | 129 |
|
|
2023
Q3 | $9.23M | Sell |
177,218
-7,703
| -4% | -$401K | 0.17% | 148 |
|
|
2023
Q2 | $11.7M | Sell |
184,921
-6,982
| -4% | -$442K | 0.2% | 128 |
|
|
2023
Q1 | $10.4M | Sell |
191,903
-3,154
| -2% | -$171K | 0.21% | 133 |
|
|
2022
Q4 | $10.3M | Sell |
195,057
-3,385
| -2% | -$179K | 0.22% | 127 |
|
|
2022
Q3 | $9.23M | Sell |
198,442
-7,583
| -4% | -$353K | 0.21% | 138 |
|
|
2022
Q2 | $11.8M | Sell |
206,025
-509
| -0.2% | -$29.1K | 0.26% | 119 |
|
|
2022
Q1 | $12.6M | Sell |
206,534
-9,987
| -5% | -$611K | 0.22% | 127 |
|
|
2021
Q4 | $11.3M | Sell |
216,521
-1,367
| -0.6% | -$71.6K | 0.2% | 136 |
|
|
2021
Q3 | $8.12M | Sell |
217,888
-7,610
| -3% | -$284K | 0.15% | 161 |
|
|
2021
Q2 | $9.21M | Buy |
225,498
+2,829
| +1% | +$115K | 0.17% | 150 |
|
|
2021
Q1 | $7.56M | Sell |
222,669
-24,525
| -10% | -$832K | 0.14% | 159 |
|
|
2020
Q4 | $7.86M | Sell |
247,194
-16,986
| -6% | -$540K | 0.16% | 142 |
|
|
2020
Q3 | $6.78M | Sell |
264,180
-11,595
| -4% | -$298K | 0.16% | 151 |
|
|
2020
Q2 | $7.08M | Buy |
+275,775
| New | +$7.08M | 0.17% | 141 |
|